Henry Gosebruch
Chief Executive Officer bij NEUMORA THERAPEUTICS, INC.
Vermogen: 9 M $ op 31-12-2023
Profiel
Henry O.
Gosebruch is currently the President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. and a Director at ACELYRIN, Inc. Previously, he served as an Independent Director at Aptinyx, Inc. from 2019 to 2023.
Prior to that, he was the Chief Strategy Officer & Executive Vice President at AbbVie, Inc. from 2015 to 2023 and Co-Head of Mergers & Acquisitions North America at JPMorgan Securities LLC from 1995 to 2015.
He received his undergraduate degree from The Wharton School of the University of Pennsylvania in 1995.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2024 | 604 793 ( 0.38% ) | 8 M $ | 31-03-2024 | |
ACELYRIN, INC.
0.05% | 09-05-2023 | 50 000 ( 0.05% ) | 337 500 $ | 31-03-2024 |
APTINYX INC
0.18% | 24-04-2023 | 125 000 ( 0.18% ) | 12 000 $ | 31-12-2023 |
Actieve functies van Henry Gosebruch
| Bedrijven | Functie | Begin |
|---|---|---|
| ACELYRIN, INC. | Director/Board Member | 29-03-2023 |
| NEUMORA THERAPEUTICS, INC. | Chief Executive Officer | 18-07-2023 |
Eerdere bekende functies van Henry Gosebruch
| Bedrijven | Functie | Einde |
|---|---|---|
| APTINYX | Director/Board Member | 04-05-2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01-02-2023 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01-12-2015 |
Opleiding van Henry Gosebruch
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| APTINYX | Health Technology |
| ACELYRIN, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
